top of page
Embrace-the-future-1920x1024 1.png

About ISS

From humble beginnings to global solutions

Company Profile

The ISS Story: A Journey of Disruption, Innovation, and Excellence

In 2010, a small team of visionaries led by Adam Warren founded Innovative Supply Solutions (ISS) with a singular mission: to disrupt the clinical trial supply chain. At a time when pharmaceutical companies struggled with inefficiencies, skyrocketing costs, and regulatory complexities, the ISS team saw an opportunity. They knew that to truly make an impact, they needed to bring technology to the forefront of clinical trial management, and ISS was born to do just that.

 

The Early Days: A Vision Takes Shape

 

The founding of ISS came from a deep understanding of the challenges that clinical trials face. Trials were delayed by supply chain bottlenecks, inventory mismanagement, and a lack of real-time visibility into operations. This resulted in delayed treatments for patients and significant financial losses for pharmaceutical companies.

 

ISS’s early focus was on providing outsourced clinical materials management services, ensuring that every piece of the supply puzzle—from kits to investigational products—was where it needed to be, when it needed to be. But this was just the beginning. The founders of ISS knew that real innovation would come not just from managing supplies, but from creating a technology solution that would give pharmaceutical companies complete visibility and control over their trials.

 

Becoming a Technology Powerhouse

 

As the years passed, ISS expanded its capabilities, and by 2018, the company transformed from a service provider into a full-fledged SaaS (Software-as-a-Service) technology company. This pivot marked a turning point in ISS’s history. The launch of ISS Nexus, a comprehensive, cloud-based platform, allowed the company to offer something truly revolutionary: real-time data insights, predictive analytics, and supply chain forecasting, all on one user-friendly platform .

 

The shift to SaaS was a bold move, but one that positioned ISS as a leader in clinical trial supply management. With ISS Nexus, users could predict supply needs, manage global inventories, and respond to potential disruptions before they impacted trial timelines. This ability to look ahead and make informed decisions transformed the way clinical trials were managed, reducing costs and improving efficiency across the board .

 

A Game-Changer: Integrating IRT

 

In 2019, ISS took its platform to the next level with the integration of Interactive Response Technology (IRT). This new functionality allowed users to automate complex processes like patient randomization, dose management, and real-time inventory tracking. What used to take weeks could now be built in just one day—an achievement that set ISS apart from competitors in the industry .

 

The IRT integration also introduced advanced logic-based supply management, which helped clinical trials operate more efficiently by ensuring the right supplies were delivered at the right time. By eliminating manual processes and enabling role-based access, ISS Nexus provided pharmaceutical companies with the control and flexibility they needed to manage their increasingly complex trials .

 

Expanding Global Reach

 

As ISS continued to innovate, it also expanded its footprint globally. By 2021, ISS Nexus had been deployed in over 1,000 clinical trials across 40 countries, supporting pharmaceutical companies in managing trials on a global scale  . Whether in North America, Europe, or Asia, the platform was trusted to streamline clinical supply chains, prevent stock-outs, and ensure patient safety through accurate, real-time data.

 

ISS’s commitment to real-time visibility and forecast accuracy was a key differentiator. The platform helped users maintain a variance of within 10% of their forecast, a feat that saved both time and money for its clients. As a result, ISS quickly earned a reputation for reliability and precision in an industry where delays and errors can mean millions in losses .

 

Building a Team of Experts

 

Behind the success of ISS is its talented and diverse team, which boasts over 50 years of combined experience in clinical operations and supply chain management . This team has been instrumental in designing, developing, and continuously improving the ISS Nexus platform, ensuring it meets the ever-evolving needs of the pharmaceutical industry. Their expertise allowed ISS to create a platform that was not only technically robust but also intuitive and flexible, making it the go-to solution for clinical operations teams globally.

 

The ISS Difference: Innovation Meets Reliability

 

What makes ISS truly unique is its ability to innovate without losing sight of what matters most: reliability. In an industry where compliance, efficiency, and patient safety are non-negotiable, ISS has developed a platform that pharmaceutical companies can depend on to deliver consistent results. From automated dose changes to seamless technology integration, every feature of ISS Nexus is designed with the user in mind, ensuring trials run smoothly and without disruption .

 

The Future: Continuing to Lead

 

Looking ahead, ISS shows no signs of slowing down. The company remains committed to pushing the boundaries of clinical trial technology to offer even more powerful capabilities in the future. As trials become more complex and regulatory requirements more stringent, ISS Nexus will continue to evolve, providing the solutions its clients need to stay ahead .

​​

Today, ISS is more than just a software provider. It is a partner in clinical trial success, helping pharmaceutical companies optimize their operations, eliminate waste, and bring life-saving treatments to patients faster than ever before.

​

bottom of page